肝硬化患者的止血改变:从初级止血到纤溶
综述探讨肝硬化时初级止血、凝血和纤溶各环节的促出血与促血栓改变,认为整体止血倾向促凝状态,但纤溶方向尚待明确,并强调病因对失衡的影响。
要点
- 肝硬化初级止血呈再平衡,凝血整体偏向促凝状态。
- 纤溶变化方向尚不明确,需进一步研究确定。
- 肝硬化病因影响止血失衡的具体表现。
核心结论
- 目前共识认为肝硬化患者止血整体偏向促凝状态。
- 纤溶系统变化是否及如何偏移尚待确定。
研究设计与样本
- 综述已发表证据,讨论肝硬化作为促血栓状态的概念及不一致数据。
主要发现
- 初级止血有多因素血小板减少和体外血小板病,但血管性血友病因子升高相抗衡,整体可能再平衡。
- 凝血因子活性降低被因子VIII升高、天然抗凝物减少及微粒、游离DNA和中性粒细胞胞外诱捕网等复杂变化所抗衡,整体呈促凝状态。
- 纤溶方面组织型和尿激酶型纤溶酶原激活物升高、纤溶酶原激活物抑制剂1相对降低、凝血酶激活纤溶抑制物和α2-抗纤溶酶降低,但被纤溶酶原降低和纤维蛋白凝块通透性降低所抗衡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In the setting of liver cirrhosis (LC), profound hemostatic changes occur, which affect primary hemostasis, coagulation, and fibrinolysis. They involve prohemorrhagic and prothrombotic alterations at each of these steps. Patients with cirrhosis exhibit multifactorial thrombocytopenia and in vitro thrombocytopathy, counterbalanced by increased von Willebrand factor. The resultant shift is difficult to assess, but overall these changes probably result in a rebalanced primary hemostasis. Concerning coagulation, the reduced activity of coagulation factors is counterbalanced by an increase in factor VIII (produced by liver sinusoidal endothelial cells), a decrease of the natural anticoagulants, and complex changes, including changes in circulating microparticles, cell-free DNA, and neutrophil extracellular traps. Overall, these alterations result in a procoagulant state. As for fibrinolysis, increased tissue-type and urokinase-type plasminogen activators, a relatively decreased plasminogen activator inhibitor 1, and decreased levels of thrombin-activatable fibrinolysis inhibitor and α2-antiplasmin are counterbalanced by decreased plasminogen and a decreased fibrin clot permeability. Whether and how these changes shift fibrinolysis remains to be determined. Overall, the current consensus is that in patients with cirrhosis, the hemostasis is shifted toward a procoagulant state. We review the published evidence for the concept of LC as a prothrombotic state, discuss discordant data, and highlight the impact of the underlying cause of LC on the resultant imbalance.
引用
- Zermatten MG, Fraga M, Moradpour D, et al. Hemostatic Alterations in Patients With Cirrhosis: From Primary Hemostasis to Fibrinolysis. Hepatology. 2020. PMID: 32090357. doi:10.1002/hep.31201
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。